ZUG, Switzerland, March 9, 2011 /PRNewswire/ -- NovaShunt AG, a private Swiss medical device company with innovative fluid management technologies, announced today that it has raised CHF 23.7 million (about $25 million) in a Series B preferred share financing round co-led by BioMedInvest AG, Entrepreneurs Fund and Capricorn Health-tech Fund.

DEERFIELD, Ill., March 9 /PRNewswire-FirstCall/ -

Five studies exploring different aspects of CHF Solutions' unique form of ultrafiltration therapy to treat fluid overload in heart failure patients (Aquapheresis™) were presented in poster sessions at the Heart Failure Society of America (HFSA) 2006 Annual Scientific Meeting in Seattle.

NovaShunt AG will present at 12.30 on 19 September 2006 at Medtech Insight's prestigious "Investment In Innovation (In3) Medical Device Summit," taking place 18-20 September in Brussels.

WILMINGTON, Mass., June 28 /PRNewswire-FirstCall/ -- CardioTech International, Inc.